CLINICAL_TRIALS
trial_result
· 2024-04-24
Clinical Trial Update: Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab [Phase 3]
Summary
Phase 3 trial update evaluating teplizumab for recent-onset type 1 diabetes; study completed with results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Provention Bio, Inc. | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2024-04-24